HCM Q2 2023 Earnings Significant EPS Beat Driven by Operational Progress Teva Q1 2026 Earnings Strong EPS Beat on Cost Discipline Shares Edge Higher VTGN Q1 2026 Earnings NarrowerthanExpected Loss Amid Clinical Progress PEBK Q4 2025 Earnings Strong EPS Performance Amid Quiet Trading BUSEP Q1 2026 Earnings 132 EPS Surprise Boosted by Solid Core Operations CTSH Q1 2026 Earnings EPS Beat Drives Positive Stock Movement